Several European countries have announced that they will resume the AstraZeneca vaccinations after the European Medicines Agency concluded that the anti-COVID vaccine is safe and effective. An extraordinary meeting of the EU medicines regulator on Thursday gave the go-ahead on the continued use of the COVID-19 vaccine.
After concluding its preliminary safety review, EMA's safety committee, the Pharmacovigilance Risk Assessment Committee, confirmed that the benefits of the vaccine in combating the still widespread threat of COVID-19 (which itself results in clotting problems and may be fatal) continue to outweigh the risk of side effects.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com